Literature DB >> 1596021

T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis.

M Azzawi1, P W Johnston, S Majumdar, A B Kay, P K Jeffery.   

Abstract

With the use of monoclonal antibodies (mAb) and immunohistology, the numbers of phenotypically distinct cells infiltrating lung tissue from 15 postmortem (PM) cases of fatal asthma were quantified and compared with 6 cases of cystic fibrosis (CF) (three postmortem, three transplant) and 10 nonasthmatic cases of sudden death matched for age and sex. Tissue eosinophilia was significantly greater (p less than 0.001) in the fatal asthma group than in the CF or sudden death controls. In asthma, approximately 40% of the eosinophilic infiltrate was EG2 positive (an indication of eosinophil activation and secretion of eosinophil cationic protein). The numbers of eosinophils and EG2 positive cells were significantly elevated in the subjects with acute severe asthma who had had a duration of terminal illness exceeding, as compared with less than, 24 h (p less than 0.05). When compared with the sudden death controls, there were increases in the numbers of Dako L C positive cells (i.e., CD45 positive "total leukocytes") in both fatal asthma and CF (p less than 0.01 and 0.05, respectively). The mean number of MT-1 positive (T) cells in the asthma and CF groups was approximately twice that of the control (p less than 0.05 and 0.01, respectively). The mean number of MB2 positive (B) cells was similar for both the asthma and sudden death control groups but was significantly increased in CF (p less than 0.05). The average T:B cell ratios were 6:1, 1:1, and 2:1 in the fatal asthma, CF, and control groups, respectively. The results support a role for the T lymphocyte in the pathogenesis of fatal asthma and CF.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1596021     DOI: 10.1164/ajrccm/145.6.1477

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  31 in total

Review 1.  New evidence of inflammation in asthma.

Authors:  A M Vignola; R Gagliardo; D Guerrera; G Chiappara; P Chanez; J Bousquet; G Bonsignore
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa.

Authors:  C Hubeau; M Lorenzato; J P Couetil; D Hubert; D Dusser; E Puchelle; D Gaillard
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

3.  Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.

Authors:  R B Moss
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

4.  Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency.

Authors:  David B Corry; Kirtee Rishi; John Kanellis; Attila Kiss; Li-zhen Song Lz; Jie Xu; Lili Feng; Zena Werb; Farrah Kheradmand
Journal:  Nat Immunol       Date:  2002-03-11       Impact factor: 25.606

5.  Evidence for eosinophil activation in bronchiectasis unrelated to cystic fibrosis and bronchopulmonary aspergillosis: discrepancy between blood eosinophil counts and serum eosinophil cationic protein levels.

Authors:  C Kroegel; M Schüler; M Förster; R Braun; P R Grahmann
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

6.  Unusual asthma syndromes and their management.

Authors:  Jaymin B Morjaria; Jack A Kastelik
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

7.  Ouabain attenuates ovalbumin-induced airway inflammation.

Authors:  José Guilherme F M Galvão; Luiz Henrique Agra Cavalcante-Silva; Deyse Cristina M Carvalho; Laércia Karla D P Ferreira; Talissa Mozzini Monteiro; Adriano Francisco Alves; Larissa Adilis M P Ferreira; Francisco Allysson A F Gadelha; Marcia Regina Piuvezam; Sandra Rodrigues-Mascarenhas
Journal:  Inflamm Res       Date:  2017-09-13       Impact factor: 4.575

8.  Topographical distribution of bronchial eosinophilia: significance for biopsy diagnosis.

Authors:  Russell P Sherwin; Valda Richters
Journal:  Virchows Arch       Date:  2009-06-03       Impact factor: 4.064

9.  Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.

Authors:  C Zuany-Amorim; D Leduc; B B Vargaftig; M Pretolani
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension.

Authors:  P P Powell; M Klagsbrun; J A Abraham; R C Jones
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.